Cannabis Law Report

SEPTEMBER 14, 2021

The new Radicle Science-OBX alliance fills an unmet need for rigorous scientific research in the cannabis industry and sets a new gold standard for CBD and minor cannabinoid product development. About Open Book Extracts. To learn more about the Radicle Science-OBX alliance, read The Movement Is On! About Radicle Science.

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

Canna Care Docs

OCTOBER 3, 2023

Natural plant therapy , and cannabis specifically, has been studied for its effectiveness in alleviating and treating many of these physiological and emotional symptoms that come into play with a terminal illness. However, many of these pharmaceutical medications can just induce more unpleasant, debilitating effects on those who are ill.

Chronic Pain 105

Chronic Pain Clinical Trials Patients Cannabinoids 105

Cannabis Law Report

OCTOBER 15, 2021

In a notice scheduled to be published in the Federal Register on Monday, the agency said there’s been a “significant increase in the use of schedule I hallucinogenic controlled substances for research and clinical trial purposes,” and it wants authorized manufacturers to meet that growing demand.

DEA 96

DEA Clinical Trials Extraction Marijuana 96

FloridaMarijuana.net

JUNE 13, 2018

For centuries, humans have relied on the cannabis plant for its therapeutic properties. More than ever, cannabis can aid in the treatment of chronic disease and as a supplement to cancer treatments. Cannabis has given cancer patients relief , improved their mood and anxiety, and relieved insomnia.

Clinical Trials 189

Clinical Trials Marijuana Patients Chronic Pain 189

FloridaMarijuana.net

AUGUST 16, 2018

The clinical trials for medications take years and to this date, there have been no effective medications to properly treat and/or cure Dementia. Within the past 30 years, there has been an increase in substantial research which supports cannabis as a medical intervention. 9-tetrahydrocannabinol (?9-THC)

Clinical Trials 184

Clinical Trials Marijuana Patients Pharmaceutical 184

Cannabis Law Report

JUNE 19, 2022

The market for psychedelic substances is projected to grow rapidly, potentially outpacing the legal US cannabis market. For example, compounds such as psilocybin, mescaline, ibogaine, and LSD are being evaluated in clinical trials, but the compounds themselves are unpatentable because their existence is well documented in the prior art.

Clinical Trials 52

Clinical Trials Microdosing Data Pharmaceutical 52

Cannabis Law Report

JUNE 20, 2021

Here’s the press release… Elisabetta Faenza has been elected to the UK-based Cannabis Industry Council (CIC) Board and has been selected to Chair its Standards Group. The CIC Standards Group consists of 28 members representing leading UK companies and advocates in the Medicinal Cannabis, CBD Nutraceutical, and Hemp sectors.

Supply Chain 105

Supply Chain Clinical Trials Research and Development Medicine 105

Cannabis Law Report

JUNE 7, 2021

Filament Health partnered with TrPR Psychedelic Research Program at UCSF to advance drug candidates through clinical trials. a federally-authorized psilocybin and cannabis research laboratory focused on extraction, analytical testing, and chemical process development. View All Index Constituents. Press Release.

Research and Development 98

Research and Development Clinical Trials Extraction Retail 98

Cannabis Law Report

AUGUST 9, 2021

Investors will continue to keep an eye on several ongoing clinical trials, as well as private companies that are gearing up to go public over the coming quarters. The PsyIndex extended its move lower over the past week, even as two companies moved to senior stock exchanges. Market Performance. Weekly Performance: $128.84 (-2.22%).

Clinical Trials 105

Clinical Trials Decriminalization Research and Development Treatment 105

Cannabis Law Report

FEBRUARY 1, 2022

Bod Australia has announced its planned phase IIB clinical trial of a cannabis extract with insomnia patients has received ethics approval. The trial will investigate the efficacy of a new prospective Schedule 3 CBD (cannabidiol) formulation on insomnia symptoms.

Clinical Trials 59

Clinical Trials CBD Medicine Extraction 59

MedicalJane

OCTOBER 3, 2019

The United States Department of Defense and GW Pharmaceuticals are collaborating on a new clinical trial at the Montefiore Medical Center in New York. Eric Hollander, the Director of the Autism and Obsessive Compulsive Spectrum Program and Anxiety and Depression Program at Montefiore Hospital, is leading the clinical trial.

Clinical Trials 74

Clinical Trials Epilepsy Pharmaceutical Treatment 74

Cannabis Law Report

JANUARY 12, 2022

OTCQB:GBLX), a leading plant-inspired, biopharmaceutical research and development company, has closed the sale of its last remaining cannabis facility, completing a transition to the biopharmaceutical industry. 14, 2021, the sale of Gb Sciences’ Las Vegas cannabis facility was finalized on Dec. LAS VEGAS, Jan.

Research and Development 52

Research and Development Clinical Trials Chronic Pain Therapy 52

SpeedWeed

JULY 23, 2021

Tyrell Towle, director of chemistry and extraction at MedPharm. This is the first time a research license for this type of work has been granted outside of state and city research licenses to study cannabis. . It took MedPharm years to get the license, but the hard work isn’t quite done yet for the ambitious Denver cannabis company.

Clinical Trials 52

Clinical Trials Research and Development DEA Cannabinoids 52

The Cannigma

MARCH 7, 2022

Yet cannabinol (CBN), the first cannabinoid ever discovered by modern scientists, is slowly making a comeback in the cannabis industry. . Of course, this plant is now known to be marijuana (or Type I cannabis), which is still commonly used for sleep and analgesia today. The best online schools for medical cannabis training.

THC 140

THC Sleep Clinical Trials Cannabinoids 140

Cannabis Law Report

JUNE 15, 2022

Materia Malta has completed the first commercial export of medical cannabis to Germany, making it the first company to export medical cannabis from Malta for sale in other countries. Materia is a leading producer and distributor of medical cannabis in Europe. Germany is Europe’s largest medical cannabis market.

Research and Development 52

Research and Development Clinical Trials Pharmaceutical Packaging 52

MedicalJane

MAY 21, 2020

Researchers at The University of New Mexico (UNM) have conducted a series of recent studies testing the effectiveness and safety of consuming cannabis, but this is the first study they have conducted measuring the therapeutic potential of hemp oil with low THC levels. This disconnect is commonly referred to as the placebo effect.

Oil 100

Oil Hemp Extraction Clinical Trials 100

MMJ Recs

APRIL 1, 2024

CBD, one of the many cannabinoids found in the cannabis plant, has been garnering attention for its promising effects on various health conditions. Furthermore, ongoing clinical trials are investigating CBD’s efficacy in treating conditions such as multiple sclerosis, Parkinson’s disease, and substance abuse disorders.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

Cannabis Law Report

JULY 29, 2021

OTTAWA, ON , July 29, 2021 /PRNewswire/ – Tetra Bio-Pharma Inc (“Tetra” or the Company”) (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and development has announced that it filed a PCT patent application for Cannabis Plant Residue and Use Thereof, PCT Patent Application No.

Research and Development 105

Research and Development Clinical Trials Events Cannabinoids 105

Cannabis Law Report

SEPTEMBER 12, 2022

Optimi will also be using the mushrooms to further develop its on-site extraction methods and will use the product to finalize its naturally derived psilocybin offerings this fall. All surplus inventory from the harvest will be safely stored in Optimi’s Level 8 Security Vault to ensure minimal degradation of the natural psilocybin.

History 52

History Clinical Trials Legalization Research and Development 52

Cannabis Law Report

JULY 24, 2021

The groundbreaking progress that we’ve seen from the Multidisciplinary Association for Psychedelic Studies (MAPS) in its Phase 3 clinical trials of MDMA-assisted psychotherapy for Post-Traumatic Stress Disorder (PTSD), including receiving Breakthrough Therapy Designation from the Food and Drug Administration (FDA), shows great promise to date.

Research and Development 105

Research and Development Clinical Trials Therapy Events 105

Cannabis Law Report

MARCH 18, 2020

The company, a leader in hemp-derived CBD extract products, has created an internal research and development division led by a former healthcare executive to focus on the science of hemp-derived phytocannabinoids, terpenes and flavonoid compounds. Charlotte’s Web Holdings, Inc. CW Labs and have an additional office in Boulder, Colo.

Clinical Trials 59

Clinical Trials Research and Development Terpenes Hemp 59

Cannabis Law Report

JANUARY 10, 2022

In addition, rising strategic initiatives by key players in the form of collaborations, clinical trials, and production are further contributing to increasing awareness and adoption of THCV products. Rising clinical trials is thus anticipated to boost the adoption and penetration of rare cannabis derivatives in the forthcoming years.

Cannabinoids 52

Cannabinoids Clinical Trials Research and Development Supply Chain 52

Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD.

DEA 66

DEA Clinical Trials THC Research and Development 66

SpeedWeed

SEPTEMBER 4, 2021

Titled “Proposed Adjustments to the Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2021,” the article specifically includes some major changes for cannabis and psilocybin. Some states in the U.S.

DEA 52

DEA Research and Development Clinical Trials Extraction 52

Cannabis Law Report

JUNE 30, 2021

In addition, the company aims to predict what treatments are most effective in addressing these conditions, including psychedelics, which have shown tremendous promise in early clinical trials. Mental Health Challenges. Psychedelics could offer a better alternative for many patients. Psychedelics Provide a Solution. Looking Ahead.

Treatment 52

Treatment Clinical Trials Research and Development Data 52

The Cannigma

DECEMBER 14, 2021

This synthetic derivative of naturally occurring delta-9-Tetrahydrocannabinol (delta-9-THC) was first reported by noted cannabis chemist Professor Roger Adams at the University of Illinois in 1940. HHC was synthesized in Adams’ laboratory as part of research to understand the active compounds in the cannabis plant.

Research and Development 116

Research and Development Cannabinoids Clinical Trials THC 116

The Joint Blog

JANUARY 31, 2021

According to a new study published in the Journal of Medical Case Reports , the daily use of high-CBD (cannabidiol) marijuana extracts is associated with improvements in the behavioral symptoms related to autism spectrum disorder (ASD). The individual was given very low-doses of marijuana extracts, no larger than 0.2 ml twice daily.

Epilepsy 62

Epilepsy Extraction Research and Development Clinical Trials 62

Otherside Farms

JANUARY 14, 2019

This has pushed into oblivion the positive impact of marijuana seeds and its extracts on various body systems, including the cardiovascular system, the brain and the reproductive system. Here are five popular medicinal uses of cannabis with low concentration of the intoxicating chemical compound tetrahydrocannabinol (THC).

Clinical Trials 49

Clinical Trials Strains Therapy Medicine 49

Cannabis Law Report

NOVEMBER 1, 2021

Traces of banned drugs have been found in nearly 200 imported cannabis-derived wellness products that have been gaining popularity in Hong Kong in recent years, a customs source has told the Post. The substance is allowed in Hong Kong as long as other prohibited ingredients derived from cannabis are not present in the products.

Wellness and Beauty 52

Wellness and Beauty CBD Clinical Trials Pharmaceutical 52

Miss Marijuana

JUNE 30, 2019

dietary supplement) Hemp Oil Extract product on various markers of physical and mental stress resilience, and perceived recovery from normal daily physical and mental stress.”. RELATED: I’m A Business Owner Who Uses Cannabis & CBD For Anxiety. The Center for Applied Health Sciences’s (CAHS) main goal for this study: .

Sleep 72

Sleep CBD Clinical Trials Oil 72

Cannabis Law Report

MAY 29, 2019

The research will focus on the optimisation of breeding and cultivating processes and the extraction of material to assess their efficacy of medical cannabis on prostate, melanoma and other cancer cells. All intellectual property from the trials will be owned by MGC, which is funding the research. Here’s the press release.

Cultivation 40

Cultivation Pharmaceutical Clinical Trials Extraction 40

Cannabis Law Report

OCTOBER 10, 2019

Clinical studies are about to get underway at an Australia university, to track changes in actual dementia patients to see if cannabis can help with dementia and related issues. As Australia’s 7News reports, the research team is currently screening candidates for the study, which will use lab-grown cannabis from Slovenia.

Treatment 40

Treatment Clinical Trials Sleep Pharmaceutical 40

Cannabis Law Report

AUGUST 19, 2021

Legal cannabis consumption and it isn’t even legal yet. If and when cannabis is actually properly regulated we’re sure the UK can be a world beater!! Cannabidiol or CBD, which is most commonly sold as oil at high street retailers, is one of the active ingredients of non-psychoactive cannabis. ” [link].

Cannabinoids 105

Cannabinoids Seed-To-Sale Clinical Trials CBD 105

Cannabis Law Report

OCTOBER 15, 2021

Last year, PAOG acquired intellectual property derived through research into CBD extracted in association with a patented extraction method (U.S. RespRx, in addition to its clinical research with COPD, has been engaged in select, non-clinical trials to treat cancer and demonstrated effectiveness. 9,199,960).

Treatment 52

Treatment Research and Development CBD eCommerce 52

Cannabis Law Report

JULY 4, 2021

CLR contributor, Brian Cusack, writes… The legalization of cannabis in Ireland has become a popular discussion around the world. While countries like Canada, Uruguay, and some states in America have legalized recreational cannabis, this isn’t a trend that has reached Ireland yet. or none at all to qualify with legal status.

THC 105

THC CBD Legalization Oil 105

The Cannigma

JUNE 23, 2022

CBGA is naturally produced by the cannabis plant, and is the precursor to all of the phyto-, or plant-related cannabinoids like THC, CBD, CBN and CBG. The CBGA is made within the trichome of the cannabis plant and is converted by specific enzymes into other cannabinoids. Common cannabinoids in cannabis. What does CBGA do?

Cannabinoids 113

Cannabinoids Research and Development Clinical Trials Extraction 113

The Cannigma

DECEMBER 12, 2022

Just as THCA in cannabis flower needs to be decarboxylated into the active compound THC, psilocybin is not active until it undergoes a chemical reaction. In 1983, Ken Nelson was likely the first person to extract and smoke Sonoran Desert Toad (aka the Colorado River toad, Incilius alvarius ) venom. It became illegal in the US in 2009.

History 119

History Microdosing Research and Development Clinical Trials 119